Voyageur Pharmaceuticals Ltd (VM) Cash Flow Statement

0.165
+0.005+3.13%

15min DelayMarket Closed Jan 22 16:00 ET

29.44MMarket Cap-8.25P/E (TTM)

Voyageur Pharmaceuticals Ltd (VM) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Aug 31, 2025

(Q2)May 31, 2025

(Q1)Feb 28, 2025

(FY)Nov 30, 2024

(Q4)Nov 30, 2024

(Q3)Aug 31, 2024

(Q2)May 31, 2024

(Q1)Feb 29, 2024

(FY)Nov 30, 2023

(Q4)Nov 30, 2023

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-2,352.15%-883.27K

-37.72%-260.69K

-653.18%-1.38M

69.50%-302.29K

-32.79%30.86K

146.78%39.22K

60.49%-189.29K

61.39%-183.07K

42.33%-991.25K

125.17%45.91K

Net income from continuing operations

-265.09%-1.3M

3.23%-544.25K

-148.54%-817.56K

-21.99%-1.71M

-62.40%-458.51K

-193.05%-357.39K

9.51%-562.4K

11.97%-328.95K

20.21%-1.4M

50.88%-282.33K

Operating gains losses

-287.34%-4.8K

-321.23%-13.51K

642.16%9.28K

181.97%1.01K

---5.1K

---1.24K

--6.11K

--1.25K

-119.92%-1.24K

----

Depreciation and amortization

-27.99%283

-27.55%284

-27.99%283

-28.15%1.57K

-28.21%392

-28.15%393

-28.21%392

-28.02%393

-76.28%2.19K

-92.23%546

Asset impairment expenditure

----

-83.66%7.94K

----

--48.61K

----

Remuneration paid in stock

229.72%241.24K

24.68%298.67K

216.07%395.3K

99.74%467.44K

142.84%29.66K

369.35%73.16K

7.80%239.55K

367.25%125.07K

12.90%234.03K

-87.39%12.22K

Other non cashItems

----

---1

-74.21%14.48K

--14.48K

Change In working capital

-43.01%184.82K

-101.48%-1.88K

-5,140.96%-966.15K

741.56%926.98K

79.98%456.47K

299.91%324.29K

231.33%127.05K

114.99%19.17K

145.19%110.15K

12.17%253.63K

-Change in receivables

-193.23%-30.71K

-79.08%-16.4K

-199.51%-17.99K

-33.85%-16.13K

-56.94%-14.58K

-159.10%-10.47K

-43.12%-9.16K

228.36%18.08K

-168.26%-12.05K

-1,108.36%-9.29K

-Change in inventory

---68.11K

---17.88K

--0

---56.5K

--0

-Change in prepaid assets

10.62%50.86K

-97.72%1.06K

80.41%-25.7K

-166.27%-33.88K

-70.47%4.99K

494.81%45.98K

-4.55%46.33K

-4,816.94%-131.18K

174.84%51.12K

-60.24%16.9K

-Change in payables and accrued expense

-19.40%232.77K

-65.12%31.35K

-797.39%-922.47K

1,354.05%1.03M

112.41%522.56K

284.94%288.78K

164.71%89.88K

219.09%132.27K

136.93%71.08K

34.21%246.02K

Cash from discontinued investing activities

Operating cash flow

-2,352.14%-883.27K

-37.72%-260.69K

-653.18%-1.38M

69.50%-302.29K

-32.79%30.86K

146.78%39.22K

60.49%-189.29K

61.39%-183.07K

42.33%-991.25K

125.17%45.91K

Investing cash flow

Cash flow from continuing investing activities

-109.19%-115.03K

46.08%-20.54K

-13.01%-42.43K

5.02%-165.96K

-6.37%-35.32K

-0.45%-54.99K

15.05%-38.1K

10.44%-37.55K

36.27%-174.72K

11.66%-33.21K

Net other investing changes

-109.19%-115.03K

46.08%-20.54K

-13.01%-42.43K

5.02%-165.96K

-6.37%-35.32K

-0.45%-54.99K

15.05%-38.1K

10.44%-37.55K

38.24%-174.72K

---33.21K

Cash from discontinued investing activities

Investing cash flow

-109.19%-115.03K

46.08%-20.54K

-13.01%-42.43K

5.02%-165.96K

-6.37%-35.32K

-0.45%-54.99K

15.05%-38.1K

10.44%-37.55K

36.27%-174.72K

11.66%-33.21K

Financing cash flow

Cash flow from continuing financing activities

27,643.40%1.56M

324.56%20.63K

304.61%1.89M

-44.41%631.73K

1,436.00%167K

-65.54%5.63K

-138.59%-9.19K

-58.80%468.28K

-6.19%1.14M

3.88%-12.5K

Net common stock issuance

--0

85.14%913.88K

-45.37%655.5K

1,436.00%167K

-96.76%530

-46.30%-5.63K

-58.86%493.6K

-3.70%1.2M

-194.74%-12.5K

Proceeds from stock option exercised by employees

31,871.12%1.63M

--90.18K

--696.9K

--5.1K

--0

--5.1K

--0

----

Net other financing activities

---68.74K

-1,856.75%-69.54K

1,221.23%283.92K

54.49%-28.88K

--0

---3.55K

60.09%-25.32K

-7.54%-63.45K

--0

Cash from discontinued financing activities

Financing cash flow

27,643.40%1.56M

324.56%20.63K

304.61%1.89M

-44.41%631.73K

1,436.00%167K

-65.54%5.63K

-138.59%-9.19K

-58.80%468.28K

-6.19%1.14M

3.88%-12.5K

Net cash flow

Beginning cash position

2,773.30%378.39K

155.85%638.99K

7,840.96%165.57K

-93.39%2.09K

61.26%3.04K

-89.39%13.17K

-61.69%249.75K

-93.39%2.09K

-96.12%31.56K

-99.29%1.88K

Current changes in cash

5,673.02%564.77K

-10.15%-260.6K

91.15%473.42K

654.63%163.48K

79,966.01%162.53K

91.71%-10.13K

55.18%-236.58K

-60.08%247.67K

96.23%-29.48K

100.09%203

End cash Position

30,975.95%943.16K

2,773.30%378.39K

155.85%638.99K

7,840.96%165.57K

61.26%3.04K

-89.39%13.17K

-61.69%249.75K

-93.39%2.09K

Free cash from

-2,352.14%-883.27K

-37.72%-260.69K

-653.18%-1.38M

69.50%-302.29K

-32.79%30.86K

146.78%39.22K

60.49%-189.29K

61.39%-183.07K

42.33%-991.25K

-15.26%45.91K

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Aug 31, 2025	(Q2)May 31, 2025	(Q1)Feb 28, 2025	(FY)Nov 30, 2024	(Q4)Nov 30, 2024	(Q3)Aug 31, 2024	(Q2)May 31, 2024	(Q1)Feb 29, 2024	(FY)Nov 30, 2023	(Q4)Nov 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-2,352.15%-883.27K	-37.72%-260.69K	-653.18%-1.38M	69.50%-302.29K	-32.79%30.86K	146.78%39.22K	60.49%-189.29K	61.39%-183.07K	42.33%-991.25K	125.17%45.91K
Net income from continuing operations	-265.09%-1.3M	3.23%-544.25K	-148.54%-817.56K	-21.99%-1.71M	-62.40%-458.51K	-193.05%-357.39K	9.51%-562.4K	11.97%-328.95K	20.21%-1.4M	50.88%-282.33K
Operating gains losses	-287.34%-4.8K	-321.23%-13.51K	642.16%9.28K	181.97%1.01K	---5.1K	---1.24K	--6.11K	--1.25K	-119.92%-1.24K	----
Depreciation and amortization	-27.99%283	-27.55%284	-27.99%283	-28.15%1.57K	-28.21%392	-28.15%393	-28.21%392	-28.02%393	-76.28%2.19K	-92.23%546
Asset impairment expenditure	----	----	----	-83.66%7.94K	----	----	----	----	--48.61K	----
Remuneration paid in stock	229.72%241.24K	24.68%298.67K	216.07%395.3K	99.74%467.44K	142.84%29.66K	369.35%73.16K	7.80%239.55K	367.25%125.07K	12.90%234.03K	-87.39%12.22K
Other non cashItems	----	----	----	----	----	----	----	---1	-74.21%14.48K	--14.48K
Change In working capital	-43.01%184.82K	-101.48%-1.88K	-5,140.96%-966.15K	741.56%926.98K	79.98%456.47K	299.91%324.29K	231.33%127.05K	114.99%19.17K	145.19%110.15K	12.17%253.63K
-Change in receivables	-193.23%-30.71K	-79.08%-16.4K	-199.51%-17.99K	-33.85%-16.13K	-56.94%-14.58K	-159.10%-10.47K	-43.12%-9.16K	228.36%18.08K	-168.26%-12.05K	-1,108.36%-9.29K
-Change in inventory	---68.11K	---17.88K	--0	---56.5K	---56.5K	--0	--0	--0	--0	--0
-Change in prepaid assets	10.62%50.86K	-97.72%1.06K	80.41%-25.7K	-166.27%-33.88K	-70.47%4.99K	494.81%45.98K	-4.55%46.33K	-4,816.94%-131.18K	174.84%51.12K	-60.24%16.9K
-Change in payables and accrued expense	-19.40%232.77K	-65.12%31.35K	-797.39%-922.47K	1,354.05%1.03M	112.41%522.56K	284.94%288.78K	164.71%89.88K	219.09%132.27K	136.93%71.08K	34.21%246.02K
Cash from discontinued investing activities
Operating cash flow	-2,352.14%-883.27K	-37.72%-260.69K	-653.18%-1.38M	69.50%-302.29K	-32.79%30.86K	146.78%39.22K	60.49%-189.29K	61.39%-183.07K	42.33%-991.25K	125.17%45.91K
Investing cash flow
Cash flow from continuing investing activities	-109.19%-115.03K	46.08%-20.54K	-13.01%-42.43K	5.02%-165.96K	-6.37%-35.32K	-0.45%-54.99K	15.05%-38.1K	10.44%-37.55K	36.27%-174.72K	11.66%-33.21K
Net other investing changes	-109.19%-115.03K	46.08%-20.54K	-13.01%-42.43K	5.02%-165.96K	-6.37%-35.32K	-0.45%-54.99K	15.05%-38.1K	10.44%-37.55K	38.24%-174.72K	---33.21K
Cash from discontinued investing activities
Investing cash flow	-109.19%-115.03K	46.08%-20.54K	-13.01%-42.43K	5.02%-165.96K	-6.37%-35.32K	-0.45%-54.99K	15.05%-38.1K	10.44%-37.55K	36.27%-174.72K	11.66%-33.21K
Financing cash flow
Cash flow from continuing financing activities	27,643.40%1.56M	324.56%20.63K	304.61%1.89M	-44.41%631.73K	1,436.00%167K	-65.54%5.63K	-138.59%-9.19K	-58.80%468.28K	-6.19%1.14M	3.88%-12.5K
Net common stock issuance	--0	--0	85.14%913.88K	-45.37%655.5K	1,436.00%167K	-96.76%530	-46.30%-5.63K	-58.86%493.6K	-3.70%1.2M	-194.74%-12.5K
Proceeds from stock option exercised by employees	31,871.12%1.63M	--90.18K	--696.9K	--5.1K	--0	--5.1K	--0	--0	--0	----
Net other financing activities	---68.74K	-1,856.75%-69.54K	1,221.23%283.92K	54.49%-28.88K	--0	--0	---3.55K	60.09%-25.32K	-7.54%-63.45K	--0
Cash from discontinued financing activities
Financing cash flow	27,643.40%1.56M	324.56%20.63K	304.61%1.89M	-44.41%631.73K	1,436.00%167K	-65.54%5.63K	-138.59%-9.19K	-58.80%468.28K	-6.19%1.14M	3.88%-12.5K
Net cash flow
Beginning cash position	2,773.30%378.39K	155.85%638.99K	7,840.96%165.57K	-93.39%2.09K	61.26%3.04K	-89.39%13.17K	-61.69%249.75K	-93.39%2.09K	-96.12%31.56K	-99.29%1.88K
Current changes in cash	5,673.02%564.77K	-10.15%-260.6K	91.15%473.42K	654.63%163.48K	79,966.01%162.53K	91.71%-10.13K	55.18%-236.58K	-60.08%247.67K	96.23%-29.48K	100.09%203
End cash Position	30,975.95%943.16K	2,773.30%378.39K	155.85%638.99K	7,840.96%165.57K	7,840.96%165.57K	61.26%3.04K	-89.39%13.17K	-61.69%249.75K	-93.39%2.09K	-93.39%2.09K
Free cash from	-2,352.14%-883.27K	-37.72%-260.69K	-653.18%-1.38M	69.50%-302.29K	-32.79%30.86K	146.78%39.22K	60.49%-189.29K	61.39%-183.07K	42.33%-991.25K	-15.26%45.91K
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More

Futubull Options Sir

Jan 19 17:47

Options Weekly 0119 | Greenland tariff standoff, gold and silver surge again, shocking reversal in Fed chair nominee! Watch Intel, Netflix earnings reports

杨杨得億

Jan 20 13:42

The real danger in the 2026 market isn't black swan events, but rather the changes you've become accustomed to ignoring.